ANAFARMA
ActiveSummary
ANAFARMA has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €313,517 and a net result of €3,778. Equity remains stable across the filed financial years (±0.5% per year). Its solvency ranks better than 77% of 22,595 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
2 directors, last change in 2024
PEETERS Ann Alida Emilia
CurrentDirector (not named in the articles)
RENS Chris Rudolf
CurrentDirector (not named in the articles)
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Not every act has been read: a resignation may still be missing
2 of this company's 3 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.
Mandate history
2 people since 2024, 2 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| PEETERS Ann Alida Emilia |
|
| RENS Chris Rudolf |
|
Owners and capital
Capital and shareholders
Capital over the years
- 05-01-2024 Converted to available equity